Finance

Senarai
Sebab 688068 menurun 5.24%?
Terokai Dengan Lebih Terperinci
688068:SHA
Beijing Hotgen Biotech Co Ltd
CN¥77.11
-5.24%
(-4.26) 1H
13 Okt, 3:00:02 PTG GMT+8  ·   CNY
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk 688068...
Buka
CN¥80.60
Tinggi
CN¥81.00
Rendah
CN¥76.00
Permodalan Pasaran
7.55B
Purata volum
2.44J
Volum
2.52J
tgi 52 mgu
CN¥214.78
rdh 52 mgu
CN¥73.44
EPS
-CN¥3.00
Bilangan pekerja
1K
Buka
CN¥80.60
Tinggi
CN¥81.00
Rendah
CN¥76.00
Permodalan Pasaran
7.55B
Purata volum
2.44J
Volum
2.52J
tgi 52 mgu
CN¥214.78
rdh 52 mgu
CN¥73.44
EPS
-CN¥3.00
Bilangan pekerja
1K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
Hotgen Biotech, often simply referred to as Hotgen, is a Chinese biological technology company founded in 2005. It focuses on the manufacture of in-vitro diagnostic instruments and reagents. In September 2019, the company was listed on the Shanghai Stock Exchange. During the novel coronavirus pandemic, it specialized in making 2019-nCoV antigen diagnostic products, which obtained EU CE certification. Hotgen was formerly a constituent of the STAR 50 Index. Headquartered in Beijing, it also established presences in foreign markets, such as the United Kingdom, France, and Germany. The net profit of the company in 2021 exceeded 2.3 billion yuan, an increase of more than sixteen times from the previous year. In 2022, its RAT kits were distributed free of charge by the Hong Kong Government to the public. In November 2023, it attended the MEDICA Trade Fair in Düsseldorf. Wikipedia
Perihal Beijing Hotgen Biotech Co Ltd
CEO-
Pekerja1.04K
Diasaskan23 Jun 2005
Ibu pejabat-
Sektor-
Laman webhotgen.com.cn
Laporan sebelumnyaSemua nilai dalam CNY
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam CNY
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
105.80J
95.17J
116.03J
151.72J
Kos barangan yang dijual
49.91J
40.31J
55.11J
36.50J
Kos hasil
49.91J
40.31J
55.11J
36.50J
Perbelanjaan penyelidikan dan pembangunan
19.65J
94.81J
49.10J
46.03J
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
83.78J
99.31J
97.60J
127.34J
Belanja kendalian
98.59J
204.82J
143.51J
186.68J
Jumlah belanja kendalian
148.50J
245.13J
198.62J
223.17J
Pendapatan kendalian
-42.70J
-149.96J
-82.59J
-71.46J
Pendapatan bukan kendalian lain
-273.76K
2.19J
-2.39J
2.09J
EBT termasuk item luar biasa
-20.92J
-155.14J
-82.67J
-76.94J
EBT tidak termasuk item luar biasa
-28.82J
-122.01J
-69.59J
-76.99J
Belanja cukai pendapatan
4.59J
-6.98J
-5.78K
-796.34K
Kadar cukai berkesan
-21.96%
4.50%
0.01%
1.03%
Belanja kendalian lain
-5.37J
6.99J
-2.96J
3.17J
Pendapatan bersih
-24.96J
-107.09J
-68.06J
-58.07J
Margin untung bersih
-23.59%
-112.52%
-58.66%
-38.27%
Perolehan bagi setiap syer
-
-
-
-
Pendapatan faedah dan pelaburan
14.98J
35.99J
15.44J
3.94J
Belanja faedah
-289.66K
-7.96J
-46.88K
-7.63J
Belanja faedah bersih
14.69J
28.03J
15.39J
-3.69J
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
-21.62J
-129.90J
-62.53J
-53.46J
Keuntungan atau kerugian daripada jualan aset
601.43K
-579.43K
-
6.83K
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google